Blood-based tumor mutational burden impacts clinical outcomes of immune checkpoint inhibitor treated breast and prostate cancers

Publication Date

2024

Content Type

Article

PubMed ID:

39623081

Additional Authors:

Additional authors and institutional affiliations

This document is currently not available here.

Share

COinS